NOTE: Not all FDA-approved bispecific antibodies are associated with a REMS protocol. January 12th 2024EP. 6: Optimizing Bispecific Use Through EMR Utilization Considerations for enhancing ...

A custom antibody manufacturer is testing the best combination of molecular parts for bispecific manufacturing. According to Stefan Schmidt, PhD, CEO of Evitria, the company offers to test in ...

Delhi, Nov. 25, 2024 (GLOBE NEWSWIRE) -- In November 2024, Jazz Pharmaceuticals announced that the US FDA granted accelerated approval for zanidatamab, a bispecific antibody, for the treatment of ...

(IN BRIEF) Roche presented new data at the ASH 2024 meeting highlighting the effectiveness of its bispecific antibodies, Columvi and Lunsumio, in treating lymphomas. Long-term studies show durable ...

New data suggests researchers may have found one of their most promising candidates yet for the next generation in immunotherapy drugs — bispecific antibodies targeting two key proteins in ...

SAN DIEGO — Compared with clinical trials, a real-world retrospective analysis has linked the bispecific antibodies epcoritamab (Epkinly) and glofitamab (Columvi) to somewhat poorer outcomes in ...

MADISON, Wis.--(BUSINESS WIRE)--Invenra Inc. is pleased to announce the launch of its Rapid Bispecific Antibody Discovery Services. Utilizing Invenra’s B-Body® Bispecific Platform, the ...

Here, we discuss strategies to select the best therapeutic antigen targets, to optimize the structure of IgG antibodies and to design related or new structures with additional functions.

MSD has an extensive pipeline in oncology but hasn't been a player in bispecific antibodies. Now, it has bolted on a bispecific via a $1.3 billion licensing deal with Curon Biopharma. The big ...

The FDA has turned down a pair of marketing applications for Regeneron’s CD20xCD3 bispecific antibody odronextamab to treat two common forms of non-Hodgkin lymphoma (NHL). The decision throws a ...

However, the new antibody design addresses these challenges. Its modular structure includes a bispecific antibody produced in bulk and a synthetic peptide tailored to individual tumors.